Table 2. Correlation between TIL density and clinicopathologic characteristics in the 220 gastric cancers.
CD3+ TIL
|
CD8+ TIL
|
CD45RO+ TIL
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Characteristics | Low | High | P-value* | Low | High | P-value* | Low | High | P-value* |
Age (years) | 0.026 | 0.250 | 0.167 | ||||||
<66 | 108 | 69 | 129 | 48 | 121 | 56 | |||
⩾66 | 34 | 9 | 35 | 8 | 34 | 9 | |||
Gender | 0.023 | 0.109 | 0.315 | ||||||
Male | 108 | 48 | 121 | 35 | 113 | 43 | |||
Female | 34 | 30 | 43 | 21 | 42 | 22 | |||
WHO classification | 0.148 | 0.008 | 0.118 | ||||||
WD | 9 | 3 | 11 | 1 | 9 | 3 | |||
MD | 50 | 23 | 58 | 15 | 53 | 20 | |||
PD | 58 | 44 | 65 | 37 | 65 | 37 | |||
Mucinous | 9 | 1 | 9 | 1 | 10 | 0 | |||
SRC | 16 | 7 | 21 | 2 | 18 | 5 | |||
Lymphatic invasion | 0.143 | 0.590 | 0.446 | ||||||
Absent | 88 | 56 | 109 | 35 | 99 | 45 | |||
Present | 54 | 22 | 55 | 21 | 56 | 20 | |||
Tumour stage | 0.095 | 0.924 | 0.366 | ||||||
T1/2 | 98 | 62 | 119 | 41 | 110 | 50 | |||
T3/4 | 44 | 16 | 45 | 15 | 45 | 15 | |||
LN metastasis | <0.001 | 0.012 | <0.001 | ||||||
Absent | 24 | 31 | 34 | 21 | 28 | 27 | |||
Present | 118 | 47 | 130 | 35 | 127 | 38 | |||
TNM stage | 0.001 | 0.250 | 0.018 | ||||||
I | 32 | 35 | 44 | 23 | 38 | 29 | |||
II | 32 | 21 | 41 | 12 | 38 | 15 | |||
III | 44 | 11 | 44 | 11 | 45 | 10 | |||
IV | 34 | 11 | 35 | 10 | 34 | 11 |
LN=lymph node; MD=moderately differentiated tubular adenocarcinoma; Mucinous=mucinous adenocarcinoma; PD=poorly differentiated tubular adenocarcinoma; SRC=signet-ring cell carcinoma; WD=well differentiated tubular adenocarcinoma.
The results were according to the density groups of TIL with mean value cutoffs.
*χ2 test was used as a statistical method.